Summary Two human ovarian (OV-MZ-10, OV-MZ-15) and two colon cancer cell lines (CO-MZ-5, CO-MZ-6) were 
A variety of human ovarian and colon carcinoma cell lines has been described in the literature (Wolf et al., 1987; Hill et al., 1987; Giancotti et al., 1989; Rutzky et al., 1979; Shi et al., 1983) . The establishment of cell lines from human cancers is a useful tool in investigating their histogenesis and carcinogenesis. Such cell lines can also be used for the evaluation of the effectiveness of new anti-cancer drugs (Fanning et al., 1990; Hills et al., 1989) , pharmacologically induced differentiation (Langdon et al., 1988) , trials of overcoming multidrug resistance or the production of MAbs against tumour-associated antigens (Miotti et al., 1987) . Therefore the establishment of new cell lines and the definite classification of the origin of each cell line are highly important. Most 
Culture conditions
The cell lines were cultured on plastic at 37TC in a 5% carbon dioxide and 95% air atmosphere. In the early phase of cultivation, the tumour cells were grown in CMRL medium (Gibco, Karlsruhe, Germany) . When the cells could be serially passaged, they were grown in Dulbecco's modified Eagle medium (DMEM, Gibco). Both media were supplemented with 10% fetal calf serum (FCS) (Gibco), penicillin (100 U ml'), streptomycin (100 pg ml-'), 1% (v/v) nonessential amino acids and sodium pyruvate and L-glutamine (2 mM).
All cell lines were frozen in liquid nitrogen at early passages and at intervals of five passages with increasing passage numbers.
Growth parameters
The rate of cellular proliferation was measured in the cultures during the logarithmic growth phase. Tumour cells (5 x 105) were seeded in 25 cm2 culture flasks and refed on day 3. From day 3 to day 9, total cell counts were determined in triplicate with the Neubauer haemocytometer.
Heterotransplantation in nude mice Tumorigenicity of three cell lines was tested by heterotransplantation in 6-to 8-week-old nu/nu mice (NMRI). The mice (n = 3 per cell line) were obtained from the Versuchstieranstalt (Hannover, Germany). Tumour cells were injected s.c.
into both flanks at an inoculum size of 1 x I07 cells each.
Histological sections of the tumours were stained with haematoxylin and eosin.
Scanning and transmission electron microscopy For scanning electron microscopy, the tumour cells were seeded on glass coverslips, fixed in situ by exposure to 2.5% phosphate-buffered glutaraldehyde solution (pH 7.2) and post-fixed in 2% osmium tetroxide solution. After dehydration in an ascending acetone series, the tumour cell monolayer was dried by the critical point method and sputtered with gold. Electron (-20C) . After air drying, the slides were stored at -20C. The immunocytochemical method used was the indirect immunoperoxidase procedure (Franke & Moll, 1987 (Franke & Moll, 1987 ; Progen); (3) MAb CK 7 against CK 7 (Boehringer, Mannheim, Germany); (4) MAb AE 14 against CK 5 (Lynch et al., 1986 ; kindly provided by T.T. Sun, New York); (5) MAb E 3 against CK 17 (Troyanovsky et al., 1989 ; kindly provided by S.M. Troyanovsky, Moscow, Russia); (6) MAb 6B10 specific for CK 4 (obtained from Euro-Diagnostics, Apeldoorn, The Netherlands); (7) MAb IT-Ks20.2 and IT-Ks20.11 against CK 20 (Moll et al., 1990 ; Progen); (8) MAb VIM-9 against vimentin (Pitz et al., 1987; Viramed, Martinsried, Germany) .
Determination of CA-125 and CEA In the supernatant The secretion of CA-125 and CEA in the supernatant was determined in proliferating and resting cells. The supernatant of exponentially growing cell cultures was collected on days 2, 4, 6 and 8 and the cells were counted. The supernatant was centrifuged at 1,000 g for 10 min and stored at -20°C until tested. The CA-125 level in the supernatant was determined by a solid-phase radioimmunoassay (RIA) (CIS, Dreieich, Germany), the CEA level by a solidphase enzyme immunoassay (EIA) (Hoffmann-LaRoche, Basle, Switzerland).
By FACScan analysis Murine monoclonal antibodies directed against CA-125 and CEA were purchased from CIS and Dianova-Immunotech (Marseille, France) respectively. Normal mouse IgGI was purchased from Becton Dickinson, FITC-conjugated goat anti-mouse IgG was obtained from Coulter (Krefeld, Germany). Quantitation of the tumourassociated surface antigens was performed on a FACScan cytofluorimeter. The cells were gently harvested by exposure to EDTA (0.05%) and filtered through a 30 tLm nylon mesh.
Cells (1 x 106) suspended in PBS were exposed to the specific or control antibody for 30 min on ice. The cells were then washed twice and resuspended in PBS containing an appropriate FITC-conjugated second MAb. After another 30 min of incubation on ice, cells were washed twice in PBS and analysed at 488 nm. Transmission electron microscopy revealed only minor differences between the ovarian (Figure la-c) and colonic ( Figure Id-f) Table IV shows the expression of the tumour-associated antigens in vivo and in vitro. In three patients the preoperative serum levels were determined. CA-125 was elevated in 2/3 patients, CEA in 3/3 patients. This was in accordance with the IRS score of the original tumour. The original sigmoid cancer and the metastasis of the ovary of CO-MZ-5 both showed an identical staining.
Results
We also performed a FACScan analysis of the cell lines. The percentage of positive cells varied from 0 to 48% for CA-125 and from 0 to 28% for CEA.
Discussion
Two human ovarian and two colon carcinoma cell lines have been newly established in permanent cell culture.
By clinical criteria, three patients were treated as ovarian cancer patients and one patient was diagnosed as having simultaneous ovarian and colon cancers. Because the cell line of this patient was established from the ovarian tumour, in the beginning all four lines were classified as ovarian cancer cell lines in our laboratory. The clinical diagnosis was fully confirmed by histopathological examinations. The tumours of the two patients that gave rise to the ovarian cancer cell lines OV-MZ-10 and OV-MZ-15 were correctly described as serous cystadenocarcinomas. The colon cell line CO-MZ-5 was derived from a patient with a tumour of both ovaries and a second tumour of the sigmoid colon. The pathologist described a serous cystadenocarcinoma of both ovaries and a second independent primary ulcerating adenocarcinoma of the colon. The tumour from which the colon cell line CO-MZ-6 was established was originally considered to be a serous cystadenocarcinoma of the ovaries. The clinical course of CO-MZ-5, however, was unusual for ovarian cancer. After a histopathologically confirmed complete remission, the patient died of progressive bone metastasis. The other patient died 8 months after diagnosis despite palliative chemotherapy of progressive intraperitoneal disease, compatible with progressive ovarian cancer.
Transmission electron microscopy showed only minor differences between the ovarian and colon carcinoma cell lines. The epithelial nature of the cell lines was confirmed by the presence of numerous desmosomes and occasional intracellular gland-like spaces. The inability to produce transplant tumours in nude mice, which became evident for the cell lines OV-MZ-15 and CO-MZ-5, did not argue against the carcinomatous derivation of these cell lines, since this phenomenon has also been reported in other human tumour cell lines (Hill et al., 1987) . The slow median doubling time of 17 days may have impeded the tumorigenesis of CO-MZ-5.
Only cytokeratin analysis enabled us to unmask the true origin of the two colonic carcinoma cell lines. The consistent expression of the simple epithelial CK polypeptides, CK 18 and CK 19, and the poor expression of stratified epithelial CKs provided support for the epithelial nature and derivation of the four lines and was in accordance with the fact that these cell lines were derived from adenocarcinomas.
The simple epithelial cytokeratin CK 7 was only expressed in ovarian carcinoma cells and was completely absent from colon carcinoma cell lines. This reflects exactly the situation in corresponding in vivo carcinomas (Moll et al., 1982; Osborn et al., 1986; van Niekerk et al., 1991) : colon carcinomas are essentially CK 7 negative (for exceptions, see van Niekerk et al., 1991; Moll et al., 1993) ; ovarian carcinomas are constantly positive. This was confirmed by our study. The colon cancer cell lines, the corresponding original tumour and the metastasis in the ovary were CK 7 negative, whereas the ovarian cancer cell lines and the original tumours were CK 7 positive. Thus, CK 7 can be used as a good discriminating marker, although it should be noted that occasionally cell lines derived from ovarian carcinoma may lose CK 7 expression (M6bus et al., 1992) .
CK 20 has been found exclusively in the colon carcinoma cell lines but not in the ovarian carcinoma lines. This result also completely agreed with the clinical situation in 'in situ' tumours. CK 20, which only recently has been introduced as a new CK polypeptide (Moll et al., 1990) , shows a very restricted tissue specificity and is only expressed at significant levels in the mucosa of small and large intestine, in the gastric foveolar epithelium, in the umbrella cells of the urothelium and in epidermal Merkel cells. This specificity is largely maintained in the corresponding carcinomas: in an extended immunohistochemical screening, 89/92 cases of colorectal adenocarcinomas expressed CK 20, whereas 31 out of 34 serous, endometrioid, anaplastic and clear cell ovarian carcinomas were completely negative and the other three were essentially negative for this CK . The expression of CK 20 is a very stable feature of normal and malignant intestinal epithelium since it is preserved in most metastases of colorectal carcinomas as well as in most established colon carcinoma cell lines (Moll et al., 1990 1993) . This statement was fully confirmed by the results of our experiments. The original tumours of the colon cancer cell lines were positive for CK 20, as was the metastasis in the ovary. The two reported colon cancer cell lines in this paper and three more colon cell lines, also established by our group, were without exception also positive for CK 20 and negative for CK 7. The original tumours of the reported ovarian cancer cell lines as well as the cell lines themselves were negative.
The only point to be considered when using CK 20 as a marker for particular pathways of epithelial differentiation, notably of the intestinal type, is the fact that ovarian mucinous tumours (both adenomas and carcinomas) also An additional discriminative marker is vimentin, which was strongly expressed in the ovarian carcinoma cell lines but essentially absent from the colon cell lines. This is again in very good agreement with the 'in situ' situation (Azumi & Battifora, 1987; Moll et al., 1991) . In previous studies, ovarian cancer cell lines all expressed vimentin, albeit at different levels (Mobus et al., 1992) .
The four cell lines also differed in their expression of tumour-associated antigens. In contrast to the detection of CK 20, however, the different levels of expression of these markers had no impact on differential diagnosis. It is well known that CA-125 is the leading tumour marker of serous cystadenocarcinoma and undifferentiated carcinoma of the ovary. In advanced disease approximately 80% of the patients have an elevated marker (Soper et al., 1990) . In contrast, CEA shows elevated serum levels in only 30-40% of ovarian cancer patients, mostly in cases of advanced disease and especially in poorly differentiated or mucinous carcinoma, which was excluded in our cell lines by histopathological examination of the original tumour. In colon cancer CEA is consistently the most important marker.
It is obvious that in the serum of the two colon cancer patients CEA was strongly elevated preoperatively. However, in one of these patients (CO-MZ-6), CA-125 was also significantly elevated, supporting the initial diagnosis of ovarian carcinoma. In the one ovarian cancer cell line tested CA-125 was elevated much more than CEA. The results of the serum values agreed with the IRS score of the primary tumour.
The results of the FACScan analysis for CA-125 were in agreement with the patient's serum level and the IRS score of the original tumour. Concerning CEA, the cells of OV-MZ-10 and CO-MZ-5 were negative by FACScan analysis although the lines were established from patients with preoperatively elevated CEA serum levels and a positive IRS score of the primary tumour. This observation suggests the possibility of a clonal selection of CEA-negative tumour cells under the conditions of long-term in vitro culture. An analogous loss of CA-125 expression after prolonged culturing of ovarian carcinoma cell lines has also been described by van Niekerk et al. (1988) and by our group (M6bus et al., 1992) .
Our group has established 40 new ovarian cancer cell lines in the past 8 years. They were all characterized exhaustively, including morphological and CK analysis. CK analysis revealed two cell lines (5%) which were highly positive for the expression of CK 20 and thus could be identified as colon cancer lines. Neither the clinical presentation or histological examination of the original tumour nor the expression of tumour-associated antigens was decisive in the differential diagnosis between colon and ovarian cancer.
Permanent cell lines are valuable tools in the examination of the biological properties of human cancers of different origins. Therefore it is important to define the origin of each cell line as exactly as possible. Although CK analysis is not a universal tool differentiating between all adenocarcinomas, we believe that the examination of any established adenocarcinoma cell line with respect to its cytokeratin expression pattern is warranted to further reduce the hazards of misclassification.
